NATCO Pharma Limited (BOM:524816)
India · Delayed Price · Currency is INR 793.35
-0.70 (-0.09%)
At close: Oct 28, 2026
NATCO Pharma Market Cap
NATCO Pharma has a market cap or net worth of 155.56 billion as of October 28, 2026. Its market cap has increased by 5.27% in one year.
Market Cap
155.56B
Enterprise Value
141.41B
Revenue
34.85B
Global Rank
n/a
Country Rank
n/a
PE Ratio
12.42
ChartMarket Cap Chart
Since March 31, 1999, NATCO Pharma's market cap has increased from 429.39M to 155.56B, an increase of 36,128.54%. That is a compound annual growth rate of 23.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2026 | 155.56B | -3.82% |
| Dec 31, 2025 | 161.75B | -34.91% |
| Dec 31, 2024 | 248.48B | 70.99% |
| Dec 29, 2023 | 145.32B | 41.73% |
| Dec 30, 2022 | 102.53B | -37.85% |
| Dec 31, 2021 | 164.98B | -5.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Wockhardt | 294.05B |
| Piramal Pharma | 259.43B |
| Cohance Lifesciences | 177.35B |
| Alivus Life Sciences | 154.94B |
| Eris Lifesciences | 153.33B |
| Alembic Pharmaceuticals | 150.65B |
| NATCO Pharma | 141.53B |
| Sudeep Pharma | 111.03B |